Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-DDI”

120 trials

Showing 20 of 120 results

Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Testing effectiveness (Phase 2)Study completedNCT00000781
What this trial is testing

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,292
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Early research (Phase 1)Study completedNCT00000772
What this trial is testing

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Study completedNCT00002429
What this trial is testing

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Who this might be right for
HIV Infections
Bristol-Myers Squibb 500
Large-scale testing (Phase 3)Study completedNCT00001022
What this trial is testing

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Large-scale testing (Phase 3)Study completedNCT00002123
What this trial is testing

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Testing effectiveness (Phase 2)Study completedNCT00002412
What this trial is testing

MKC-442 in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00001114
What this trial is testing

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT00002109
What this trial is testing

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

Who this might be right for
HIV Infections
Immunobiology Research Institute
Early research (Phase 1)Study completedNCT00000669
What this trial is testing

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00000770
What this trial is testing

A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Testing effectiveness (Phase 2)Study completedNCT00001122
What this trial is testing

An Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 74
Early research (Phase 1)Study completedNCT04630002
What this trial is testing

Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR)

Who this might be right for
HIV Infections
ViiV Healthcare 54
Testing effectiveness (Phase 2)Study completedNCT00000671
What this trial is testing

A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 750
Early research (Phase 1)Study completedNCT00000753
What this trial is testing

A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT00116415
What this trial is testing

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Who this might be right for
HIV InfectionsAIDS
Bristol-Myers Squibb 65
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation